NewCures is a Northwestern initiative that focuses on accelerating biomedical research from early discovery stages to more advanced clinical stages or commercialization for the benefit of the patients.
- To accelerate development and translation of biomedical projects to a decision point
- To mentor NU’s biomedical leaders to advance their research to commercialization opportunities
- To strengthen NU’s therapeutics pipeline to ultimately benefit the public
NewCures will align with existing resources and propel therapies towards commercialization of Northwestern IP. Successful projects should be based on a lead compound and be gearing towards validation experiments.